Loading clinical trials...

Gastric Emptying Using Two Imaging Methods for Those Who Have Undergone POSE2 Weight Loss Procedure | Clinical Trials | Clareo Health

TERMINATED

Gastric Emptying Using Two Imaging Methods for Those Who Have Undergone POSE2 Weight Loss Procedure

Direct Comparison of Short- And Long-Term Gastric Emptying By Nuclear Scintigraphy and Gastric Emptying Breath Test in Subjects Undergoing Endoscopic Gastric Remodeling For Weight Loss

NCT04502732•Mayo Clinic

View on ClinicalTrials.gov

Summary

The purpose of this study is to compare a less invasive breath test against the current standard for assessing gastric (stomach) emptying. The current standard of care is a procedure called Nuclear Scintigraphy of a Solid Meal (NSSM). This study will compare this method to a Gastric Emptying Breath Test (GEBT).

Eligibility

Age

22 - 65 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Subjects must be 22-65 years of age at time of enrollment
•Subjects must already be consented to 17-007934 or 19-001254
•Subject must be agreeable and compliant with study requirements, including up to three (baseline, 2 month, and 6 month) visits, as well as undergoing GEBT and NSSM testing.
•If female, must be post-menopausal, surgically sterile, or agree to practice a form of birth control or abstinence during year of study and have negative serum HCG at screening/baseline
•Must be willing and able to travel, as needed, to the Investigator's office to complete all routine follow-up visits

Exclusion Criteria

•Persons presently or soon to be incarcerated
•Females who are pregnant or suspect they may be pregnant
•Persons with nicotine and/or alcohol dependence
•Patients with cognitive impairment that limits their ability to make autonomous decisions
•Known allergies or sensitivities to study materials (eggs and spirulina)
•Assessed, by the physician or delegate, that enrollment would not be appropriate

Locations (1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States

Key Dates

Start Date

July 16, 2020

Primary Completion Date

November 23, 2020

Completion Date

November 23, 2020

Last Updated

November 2, 2023

Enrollment

ACTUAL participants

Conditions

Weight Loss

Interventions

NSSM and GEBT

OTHER

Protein Supplementation Intervention on Body Weight

NCT06989203

ObesityWeight Loss+1 more

View study

RECRUITINGPHASE3

VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

NCT07104383

Weight Loss

View study

RECRUITINGNA

WISE-2B Brain Study (Weight Loss Intervention Surgical Effects on Brain Function)

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: November 2, 2023Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Gastric Emptying Using Two Imaging Methods for Those Who Have Undergone POSE2 Weight Loss Procedure

Inclusion Criteria

Exclusion Criteria

Protein Supplementation Intervention on Body Weight

VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)

WISE-2B Brain Study (Weight Loss Intervention Surgical Effects on Brain Function)

Dyad Plus Effectiveness/Feasibility

Family COMIDA (Consumo de Opciones Más Ideales De Alimentos) (Eating More Ideal Food Options)

Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults